| 1. |
Byhahn C, Strouhal U, Martens S, et al. Incidence of gastrointestinal complications in cardiopulmonary bypass Patients. World J Surg, 2001, 25: 1140-1144.
|
| 2. |
方駿, 肖穎彬, 陳林, 等. 谷氨酰胺二肽對體外循環心臟手術患者腸粘膜屏障的保護作用. 第三軍醫大學學報, 2005, 27(2): 2067-2069 .
|
| 3. |
何桂珍. 腸道屏障功能與細菌移位. 協和醫學雜志, 2012, 7(3): 260-264.
|
| 4. |
龍村, 鄧碩增. 體外循環對消化系統的影響. 國外醫學麻醉學與復蘇分冊, 1998, 5: 170-172.
|
| 5. |
張紅民, 李欽傳, 王永武. 體外循環對內毒素影響的實驗研究. 同濟大學學報, 2001, 22(4): 8-10.
|
| 6. |
劉大為, 主編. 實用重癥醫學. 第1版. 北京: 人民衛生出版社. 2010. 657-659.
|
| 7. |
任海波, 劉彬, 李穎, 等. 降鈣素原在體外循環心臟術后早期并發癥中的預測價值研究. 內科急危重癥雜志, 2014, 20(4): 248-250.
|
| 8. |
Aydin NB, Gecrekoglu H, Aksu B, et al. Endotoxemia in coronary artery bypass surgery: comparison of the off-pump technique and conventional cardiopulmonary bypass. J Thorac Cardiovasc Surg, 2003, 125(4): 843-848.
|
| 9. |
Mangi A, Christison-Lagay ER, Torchiana DF, et al. Gastrointestinal complications in patients undergoing heart operation: an analysis of 8709 consecutive cardiac surgical patients. Ann Surg, 2005, 241: 895-904.
|
| 10. |
Working group report. Guidelines for the evaluation of probiotics in food, joint food and agriculture organization of the United Nations and the World Health Organization. 2007.
|
| 11. |
孫瑩杰, 曹惠鵑, 張鐵錚, 等. 益生菌對體外循環后大鼠腸黏膜通透性和細菌易位的影響. 沈陽部隊醫藥, 2010, 23(4): 224-227.
|
| 12. |
陳海良, 楊育林. 口服益生菌對大腸癌術后患者炎癥反應及腸道屏障功能的影響. 中國中西醫結合消化雜志, 2014, 2(22): 38-40.
|
| 13. |
Cross ML. Microbes versus microbes: immune signals generated by probiotic Lactobacilli and their roe in protection against microbial pathogens. FEMS Immunol Med Micmbiol, 2002, 34(4): 245-248.
|
| 14. |
王平, 蘭梅. 乳果糖聯合雙岐菌治療肝硬化療效及對血清二胺氧化酶和內毒素的影響. 上海預防醫學, 2014, 26(4): 219-220.
|
| 15. |
胡長征. 乳果糖對肝硬化患者內毒素血癥的影響. 中西醫結合肝病雜志, 2004, 14(4): 241-242.
|
| 16. |
龍村, 主編. 體外循環學. 第1版. 北京: 人民軍醫出版社, 2004. 49-50.
|
| 17. |
Tan M, Zhu JC, Du J, et al. Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcome in severe traumatic brain-injured patients: a prospective randomized pilot study. Criti Care, 2011, 15(6): 290.
|
| 18. |
Drouault-Holowaez S, Foligne B, Dennin V, et al. Anti-inflammatory potential of the probiotic dietary supplement lactibiane tolerance: intro and in vivo considerations. Clin Nutrit, 2006, 25(6): 994-1003.
|
| 19. |
Morroe LE, Gogineni V, Malesker MA. Probiotic, prebiotic and synbiotic use in critically ill patients. Curr Opin Crit Care, 2012, 18(2): 186-191.
|
| 20. |
Petrof EO, Dhaliwal R, Manzanares W, et al. Probiotics in the critically ill: a systematic review of the randomized trial evidence. Crit Care Med, 2012, 40(12): 3290-3302.
|
| 21. |
Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev, 2011, 9(11): 4827.
|
| 22. |
欒嶸, 唐惠林, 翟所迪. 益生菌制劑預防呼吸機相關性肺炎的系統評價. 中國醫院藥學雜志, 2014, 34(3): 208-215.
|
| 23. |
童鋒, 應佑華, 郭松永, 等. 早期腸內營養聯合益生菌在胃腸道創傷患者術后的應用. 中華危重癥醫學雜志, 2012, 5(6): 33-36.
|